ArticleFrontiers in pharmacology2023

Fangji Dihuang formulation ameliorated DNCB-induced atopic dermatitis-like skin lesions by IL-17 signaling pathway: integrating network analysis and experimental validation.

Wenting Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.